TGFB1 and breast carcinoma: As knockdown of USP26 potently activated the TGF‐β pathway in breast cancer, we investigated whether depletion of USP26 in the TGF‐β‐responsive metastatic cell line MDA‐MB‐231 enhanced cellular motility and invasion.